These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 28542740

  • 41. Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study.
    Casabonne D, Benavente Y, Seifert J, Costas L, Armesto M, Arestin M, Besson C, Hosnijeh FS, Duell EJ, Weiderpass E, Masala G, Kaaks R, Canzian F, Chirlaque MD, Perduca V, Mancini FR, Pala V, Trichopoulou A, Karakatsani A, La Vecchia C, Sánchez MJ, Tumino R, Gunter MJ, Amiano P, Panico S, Sacerdote C, Schmidt JA, Boeing H, Schulze MB, Barricarte A, Riboli E, Olsen A, Tjønneland A, Vermeulen R, Nieters A, Lawrie CH, de Sanjosé S.
    Int J Cancer; 2020 Sep 01; 147(5):1315-1324. PubMed ID: 32012253
    [Abstract] [Full Text] [Related]

  • 42. MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma.
    Preis M, Gardner TB, Gordon SR, Pipas JM, Mackenzie TA, Klein EE, Longnecker DS, Gutmann EJ, Sempere LF, Korc M.
    Clin Cancer Res; 2011 Sep 01; 17(17):5812-21. PubMed ID: 21652542
    [Abstract] [Full Text] [Related]

  • 43. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
    Xue WX, Zhang MY, Rui Li, Liu X, Yin YH, Qu YQ.
    Biomed Res Int; 2020 Sep 01; 2020():9601876. PubMed ID: 32724822
    [Abstract] [Full Text] [Related]

  • 44. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China.
    Jiang L, Cheng Q, Zhang BH, Zhang MZ.
    Medicine (Baltimore); 2015 Mar 01; 94(10):e603. PubMed ID: 25761179
    [Abstract] [Full Text] [Related]

  • 45. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q.
    Tumour Biol; 2016 Jun 01; 37(6):7777-84. PubMed ID: 26695145
    [Abstract] [Full Text] [Related]

  • 46. Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma.
    Nesteruk K, Levink IJM, de Vries E, Visser IJ, Peppelenbosch MP, Cahen DL, Fuhler GM, Bruno MJ.
    Pancreatology; 2022 Jun 01; 22(5):626-635. PubMed ID: 35613957
    [Abstract] [Full Text] [Related]

  • 47. Circulating microRNAs as diagnostic biomarkers for pancreatic cancer.
    Le Large TY, Meijer LL, Prado MM, Kazemier G, Frampton AE, Giovannetti E.
    Expert Rev Mol Diagn; 2015 Jun 01; 15(12):1525-9. PubMed ID: 26567751
    [Abstract] [Full Text] [Related]

  • 48. Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study.
    van der Sijde F, Homs MYV, van Bekkum ML, van den Bosch TPP, Bosscha K, Besselink MG, Bonsing BA, de Groot JWB, Karsten TM, Groot Koerkamp B, Haberkorn BCM, Luelmo SAC, Mekenkamp LJM, Mustafa DAM, Wilmink JW, van Eijck CHJ, Vietsch EE, On Behalf Of The Dutch Pancreatic Cancer Group.
    Int J Mol Sci; 2021 Oct 09; 22(20):. PubMed ID: 34681562
    [Abstract] [Full Text] [Related]

  • 49. Dysregulation of miRNAs Targeting the IGF-1R Pathway in Pancreatic Ductal Adenocarcinoma.
    Dobre M, Herlea V, Vlăduţ C, Ciocîrlan M, Balaban VD, Constantinescu G, Diculescu M, Milanesi E.
    Cells; 2021 Jul 22; 10(8):. PubMed ID: 34440625
    [Abstract] [Full Text] [Related]

  • 50. Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico.
    Álvarez-Hilario LG, Salmerón-Bárcenas EG, Ávila-López PA, Hernández-Montes G, Aréchaga-Ocampo E, Herrera-Goepfert R, Albores-Saavedra J, Manzano-Robleda MDC, Saldívar-Cerón HI, Martínez-Frías SP, Thompson-Bonilla MDR, Vargas M, Hernández-Rivas R.
    Int J Mol Sci; 2023 Oct 14; 24(20):. PubMed ID: 37894871
    [Abstract] [Full Text] [Related]

  • 51. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q, Yu Z, Yuan S, Xie W, Li C, Hu Z, Xiang Y, Wu N, Wu L, Bai L, Li Y.
    Oncotarget; 2017 Feb 21; 8(8):13048-13058. PubMed ID: 28055956
    [Abstract] [Full Text] [Related]

  • 52. Plasma microRNA ratios associated with breast cancer detection in a nested case-control study from a mammography screening cohort.
    Chiorino G, Petracci E, Sehovic E, Gregnanin I, Camussi E, Mello-Grand M, Ostano P, Riggi E, Vergini V, Russo A, Berrino E, Ortale A, Garena F, Venesio T, Gallo F, Favettini E, Frigerio A, Matullo G, Segnan N, Giordano L.
    Sci Rep; 2023 Jul 25; 13(1):12040. PubMed ID: 37491482
    [Abstract] [Full Text] [Related]

  • 53. MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.
    du Rieu MC, Torrisani J, Selves J, Al Saati T, Souque A, Dufresne M, Tsongalis GJ, Suriawinata AA, Carrère N, Buscail L, Cordelier P.
    Clin Chem; 2010 Apr 25; 56(4):603-12. PubMed ID: 20093556
    [Abstract] [Full Text] [Related]

  • 54. MicroRNA-26a-5p is a reliable biomarker in the adjuvant setting for pancreatic ductal adenocarcinoma.
    Takeda Y, Yamada D, Kobayashi S, Sasaki K, Iwagami Y, Tomimaru Y, Noda T, Takahashi H, Asaoka T, Shimizu J, Doki Y, Eguchi H.
    PLoS One; 2024 Apr 25; 19(9):e0310328. PubMed ID: 39288140
    [Abstract] [Full Text] [Related]

  • 55. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer.
    Wang WS, Liu LX, Li GP, Chen Y, Li CY, Jin DY, Wang XL.
    Cancer Prev Res (Phila); 2013 Apr 25; 6(4):331-8. PubMed ID: 23430754
    [Abstract] [Full Text] [Related]

  • 56. An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study.
    Nakamura K, Zhu Z, Roy S, Jun E, Han H, Munoz RM, Nishiwada S, Sharma G, Cridebring D, Zenhausern F, Kim S, Roe DJ, Darabi S, Han IW, Evans DB, Yamada S, Demeure MJ, Becerra C, Celinski SA, Borazanci E, Tsai S, Kodera Y, Park JO, Bolton JS, Wang X, Kim SC, Von Hoff D, Goel A.
    Gastroenterology; 2022 Nov 25; 163(5):1252-1266.e2. PubMed ID: 35850192
    [Abstract] [Full Text] [Related]

  • 57. Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson's disease.
    Xie S, Niu W, Xu F, Wang Y, Hu S, Niu C.
    Int J Neurosci; 2022 Jul 25; 132(7):673-688. PubMed ID: 33045885
    [Abstract] [Full Text] [Related]

  • 58. Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma.
    Yu J, Ploner A, Kordes M, Löhr M, Nilsson M, de Maturana MEL, Estudillo L, Renz H, Carrato A, Molero X, Real FX, Malats N, Ye W.
    Int J Cancer; 2021 Apr 15; 148(8):2048-2058. PubMed ID: 33411965
    [Abstract] [Full Text] [Related]

  • 59. A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study.
    Debernardi S, O'Brien H, Algahmdi AS, Malats N, Stewart GD, Plješa-Ercegovac M, Costello E, Greenhalf W, Saad A, Roberts R, Ney A, Pereira SP, Kocher HM, Duffy S, Blyuss O, Crnogorac-Jurcevic T.
    PLoS Med; 2020 Dec 15; 17(12):e1003489. PubMed ID: 33301466
    [Abstract] [Full Text] [Related]

  • 60. MicroRNA-125a-3p, -4530, and -92a as a Potential Circulating MicroRNA Panel for Noninvasive Pancreatic Cancer Diagnosis.
    Seyed Salehi A, Parsa-Nikoo N, Roshan-Farzad F, Shams R, Fathi M, Asaszadeh Aghdaei H, Behmanesh A.
    Dis Markers; 2022 Dec 15; 2022():8040419. PubMed ID: 36254252
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.